Delivery Order 75N95022D00022-75N95022F00001

Award Date 9/30/22
Potential Completion Date 11/30/22
Potential Value $11K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20190, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the prime contractor Leidos, Inc. The contract provides $204,322 in funding for administrative management and technical support activities for the development of biopharmaceutical products for infectious diseases, continuing a multi-year effort. Leidos, operating through its Leidos Services Operating Segment...
Leidos, Inc., doing business as Saic, has been awarded a $170,174.19 delivery order by the Defense Health Agency to provide research and engineering support services. The contract has no set-aside designation and calls for Leidos to perform the work through November 30, 2017 at Fort Detrick, Maryland. Leidos, Inc. is a subsidiary of Leidos Holdings, Inc., which does business as Leidos and specializes in information technology, engineering, and science solutions for government customers such as...
This is a delivery order awarded to Leidos, Inc. (doing business as SAIC) by the Department of Health and Human Services National Institutes of Health Clinical Center. The contract has a potential value of $101,485,979.16 and is a time and materials type contract. It is a task order under the Chief Information Officer - Solutions and Partners 3 (CIO-SP3) government-wide acquisition contract (GWAC). There is no set-aside designation mentioned. The contract provides for the delivery of information...
Leidos, Inc., doing business as Saic, has been awarded a $103,002.98 cost-plus-fixed-fee delivery order against an unspecified contract vehicle to provide meeting support services for the Fiscal Year 2019 Clinical and Rehabilitative Research Program Meeting at Fort Detrick, Maryland. No set-aside designation was used for this award from the Defense Health Agency. As the prime contractor, Leidos will leverage its expertise in systems integration, scientific research, and healthcare solutions to...
Leidos, Inc., doing business as Saic, has been awarded a $465,991.24 delivery order against an indefinite delivery vehicle by the Defense Health Agency. The order is for research and engineering support services under the Global War on Terrorism Infectious Disease research program. Work will be performed at Fort Detrick, Maryland, with a period of performance through November 2017. No set-aside designation was applied to this order. Leidos, Inc. is a subsidiary of Leidos Holdings, Inc., which...
Leidos, Inc., doing business as Saic, has been awarded a $143,212.51 time-and-materials delivery order by the Defense Health Agency to provide general program support under the Scientific and Innovation Research Program for fiscal year 2015. The work will be performed at Fort Detrick, Maryland, with an anticipated completion date of April 30, 2016. As the prime contractor, Leidos will leverage its expertise in information technology, engineering, and science to support the Defense Health...
This federal contract award, valued at $1,441,582.02, was issued by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to the prime contractor Leidos, Inc. The award is for a Delivery Order contract type with a Time and Materials pricing structure. The contract is for the C-2612 FUNDING BASE PERIOD and has an ultimate completion date of October 12, 2013. Leidos, Inc. operates through its Leidos Services Operating Segment Division...
Leidos, Inc., doing business as Saic, has been awarded a $102,142.18 cost-plus-fixed-fee delivery order against an unidentified indefinite delivery vehicle by the Defense Health Agency. To be performed in Fort Detrick, Maryland through December 2019, the order is in support of the agency's Fiscal Year 2018 Chemical and Biological Defense Research, Development, Test, and Evaluation Program. No set-aside designation was used for this award. As the prime contractor, Leidos will leverage its...
This is a $158,987.57 cost-plus-fixed-fee delivery order contract awarded by the Defense Health Agency to Leidos, Inc. for FY19 SCIRP (Spinal Cord Injury Research Program) meeting support services. The contract has no set-aside designation and an ultimate completion date of June 6, 2020. Leidos, operating through its Leidos Services Operating Segment division and doing business as SAIC, is a global provider of IT, engineering, and scientific solutions to U.S. government agencies. This award...
This contract was awarded by the Defense Health Agency (DHA) to Leidos, Inc. (Leidos) for delivery order services. The contract has a potential value of $5,617,571.35 and is a cost-plus-fixed-fee type. The contract does not have a set-aside designation. Leidos, through its Leidos Services Operating Segment doing business as Science Applications International Corporation (SAIC), provides a range of IT, engineering, and scientific solutions to federal agencies, including the DHA. This contract...

Leidos, Inc., operating as Saic, has been awarded a $10,736.20 delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke's Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders indefinite-delivery/indefinite-quantity multiple award contract. The two month order is for a contract kickoff meeting and project management plan in support of the master contract's scope to aid development of biotechnology treatments for neurological conditions. Performance will take place in Herndon, Virginia under a firm fixed price arrangement. No set aside designation was specified.

Generated 12/30/23, 12:17 PM